Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Virology|October 4, 2024
Human and hamster sera correlate well in identifying antigenic drift among SARS-CoV-2 variants, including JN.1Wei Wang, Gitanjali Bhushan, Stephanie Paz, et al.
The Journal of Infectious Diseases|July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2021
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responsesEric D Laing, Spencer L Sterling, Stephanie A Richard, et al.
Open Forum Infectious Diseases|February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During InfectionF Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Open Forum Infectious Diseases|July 25, 2022
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Nusrat J Epsi, David A Lindholm, et al.
Pageof 3